Literature DB >> 2114444

Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549.

B L Rothman1, A W Despins, D L Kreutzer.   

Abstract

A growing body of literature suggests that a variety of cell products (e.g., cytokines, C components, etc.) likely play an important role during inflammation and host defense by locally regulating the diverse functions of recruited (i.e., immunologic cells) as well as tissue cells. Previously, a number of investigations have demonstrated the ability of immunologic cells to produce C components in vitro, and further studies have identified a variety of cytokines that can regulate C component production by these cells. Recently, we have demonstrated the ability of lung tissue cells, including epithelial cells and fibroblasts, to synthesize and secrete numerous C components and complement regulatory proteins in vitro. Additionally, we have demonstrated that C component production can be modulated by a variety of factors including endotoxin and serum. In our studies we investigated the effects of specific cytokines, i.e., IL and IFN, on the production of the third (C3) and fifth (C5) C components by the continuous cell line of human type II pneumocytes (A549). Specifically, using sensitive ELISA we demonstrated that A549 pneumocytes exposed to IL-1 alpha, IL-1 beta, or IL-2 induced a dose-dependent, more than twofold, increase in C3 production and a 50% decrease in C5 production when compared to control (untreated) A549 cells. Interestingly, IFN-alpha significantly decreased both C3 and C5 production, i.e., 38 and 71%, respectively, in a dose-dependent manner. IFN-gamma had no effect on C3 production, but significantly decreased C5 production by A549 pneumocytes by 84%. These data not only demonstrate that cytokines have the capability to modulate C3 and C5 production by human type II pneumocytes in vitro, but that C3 and C5 production by these cells can be regulated independently by different cytokines. In vivo, cytokine modulation of C component production by local tissue cells likely plays an important role in the regulation of inflammation and host defense within the lung.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114444

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells.

Authors:  Dachun Wang; David L Haviland; Alan R Burns; Eva Zsigmond; Rick A Wetsel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

2.  Molecular characterization of complement components (C3, C4, and factor B) in human saliva.

Authors:  A Andoh; Y Fujiyama; T Kimura; H Uchihara; H Sakumoto; H Okabe; T Bamba
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.

Authors:  S Varsano; M Kaminsky; M Kaiser; L Rashkovsky
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

4.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

5.  Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.

Authors:  M F Bernet-Camard; M H Coconnier; S Hudault; A L Servin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.

Authors:  E N Janoff; C Fasching; J M Orenstein; J B Rubins; N L Opstad; A P Dalmasso
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

7.  Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells.

Authors:  K K Christian-Ritter; L D Hill; E B Hoie; T L Zach
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells.

Authors:  Beatriz de Astorza; Guadalupe Cortés; Catalina Crespí; Carles Saus; José María Rojo; Sebastián Albertí
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  C3 synthesis by A549 alveolar epithelial cells is increased by interferon-gamma and dexamethasone.

Authors:  L D Hill; L Sun; M P Leuschen; T L Zach
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.